Molecules/ALEFACEPT

ALEFACEPT

Molecular Identity

ProteinApprovedFirst approved 2003

Mechanism of action: T-cell surface antigen CD2 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ALEFACEPTAMEVIVEBG-9273BG9273BG-9712BG9712HUMAN LFA-3IGG FUSION PROTEINLFA-3CD2LFA-3TIPLFA3TIP

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ALEFACEPT

Loading drug network...